Inhibikase Therapeutics (IKT) Revenue (2020 - 2023)
Inhibikase Therapeutics (IKT) reported Revenue of $1.0 for Q4 2023, down 100.0% year-over-year from $63566.0 in Q4 2022, and down 100.0% quarter-over-quarter from $79569.0 in Q3 2023.
Inhibikase Therapeutics (IKT) Revenue (2020 - 2023) Analysis & Trends
Inhibikase Therapeutics (IKT) has 4 years of Revenue data on file, last reported at $1.0 in Q4 2023.
- Revenue for Q4 2023 came in at $1.0, down 100.0% year-over-year; the trailing twelve-month figure through Sep 2024 was $1.0 (down 100.0% YoY), and the FY2023 annual result was $260501.0, up 111.03% from the prior year.
- Revenue declined to $1.0 in Q4 2023 per IKT's latest filing, from $79569.0 in the prior quarter.
- Over five years, Revenue peaked at $1.4 million in Q1 2021 and troughed at $1.0 in Q4 2023.
- A 4-year average of $261438.4 and a median of $72045.0 in 2023 frame the typical range for Revenue.
- The sharpest annual moves came in 2022 and 2023: Revenue soared 3169.86% in 2022, then slumped 100.0% in 2023.
- A 4-year view of Revenue shows it stood at $170416.0 in 2020, then slumped by 98.86% to $1944.0 in 2021, then soared by 3169.86% to $63566.0 in 2022, then tumbled by 100.0% to $1.0 in 2023.
- Business Quant data shows IKT's Revenue at $1.0 in Q4 2023, $79569.0 in Q3 2023, and $116410.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 5.21 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 306.30 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 2.99 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Inhibikase Therapeutics | 285.17 Mn | 114.80 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 1.00 |
| Sep 30, 2023 | 79,569.00 |
| Jun 30, 2023 | 116,410.00 |
| Mar 31, 2023 | 64,521.00 |
| Dec 31, 2022 | 63,566.00 |
| Sep 30, 2022 | 7,291.00 |
| Jun 30, 2022 | 6,552.00 |
| Mar 31, 2022 | 46,031.00 |
| Dec 31, 2021 | 1,944.00 |
| Sep 30, 2021 | 328,459.00 |
| Jun 30, 2021 | 1.36 Mn |
| Mar 31, 2021 | 1.41 Mn |
| Dec 31, 2020 | 170,416.00 |
| Sep 30, 2020 | 37,680.00 |
| Jun 30, 2020 | 219,585.00 |
| Mar 31, 2020 | 270,787.00 |